News & Press: Latest News

MDMA Creates “COVID-19 Working Group” to Coordinate Industry Efforts

Tuesday, March 17, 2020  
Share |

MDMA Creates “COVID-19 Working Group” to Coordinate Industry Effort

As MDMA continues to coordinate with various policy makers, federal, state and local agencies to help address the COVID-19 pandemic, we also want to provide resources for medical technology innovators on the latest developments and information coming from Washington, DC and state legislatures.

The ongoing spread of COVID-19 is an issue that is changing rapidly, and MDMA remains in regular contact with Administration officials and Members of Congress, as well as state government officials.

MDMA has created a “COVID-19 Working Group” that shares the latest policy updates and identifies strategies and solutions on how medical technology innovators can help address this crisis, and how policy makers can develop legislation that will support the ongoing development of lifesaving and life-sustaining technologies. Please email Emma Huther at to JOIN THIS WORKING GROUP.

MDMA will continue to work closely with the dynamic innovators that make up the medical technology industry to confront the COVID-19 pandemic, and ensure that patients, physicians and all health care professionals have access to the lifesaving and life-sustaining technologies that our ecosystem develops.